PenderFund Capital Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

PenderFund Capital Management’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-635,800	Closed	-$862K	–	153
2023 Q3	$862K	Buy	+635,800	New	+$487K	0.26%	63

PenderFund Capital Management's CELL Position: Q4 2023 in Review

PenderFund Capital Management sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2023, closing a stake of 635,800 shares — an estimated $862K sold.

PenderFund Capital Management first reported a position in CELL in Q3 2023 and held it in 1 quarter. The position peaked at $862K in Q3 2023. 0 funds tracked by Wall St. Rank hold CELL as of Q4 2023.

PenderFund Capital Management reported no remaining PhenomeX Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
PenderFund Capital Management sold 635,800 PhenomeX Inc. Common Stock shares in Q4 2023, an estimated $862K.
PenderFund Capital Management first reported a position in PhenomeX Inc. Common Stock in Q3 2023 and held it in 1 quarter.
PenderFund Capital Management's PhenomeX Inc. Common Stock position peaked at $862K in Q3 2023.
0 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2023.

Based on PenderFund Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.